Angela Radcliffe

Oracle's Ken Glueck writes last week of his competition: "Everyone in the industry understands that Epic’s CEO Judy Faulkner is the single biggest obstacle to EHR interoperability. She opposes interoperability because it threatens Epic’s franchise. By contrast, Oracle believes outcomes are easier to obtain when providers can collaborate and gain insights across systems, data, and application silos." Which is not incorrect. But markets are about power and control, of getting 'others' to build on and sustain the economic system you started. They're about gravitational pull into your orbit, not technical push into someone else's. And Epic, like UnitedHealth Group and Express Scripts by Evernorth and Mercer, are 'control points' in the American Way of Healthcare. They are the Big EHR and Big Payer and Big PBM and Big EBC writing the source code to keep their flywheels going. They're the apex predators in a blow-up-your-brain ecology of complexity and fragmentation that's getting worse, not better. But if you understand how to #position leverage, if you're fluent in systems thinking, and if you approach #growth as a function of market innovation told and sold with a unique strategy story, then it becomes simple to see space to displace 'the system' that can't be "fixed". Everyone is vulnerable. Published two years ago on #FreshPaint, the Blue Spoon platform dedicated to breaking the hold and the mold of #groupthink keeping healthcare stuck in low-Earth orbit. cc: Chris Gibson, Bharat Sutariya, Michael Fronstin, Nasim Afsar, MD MBA MHM, Brenna Quinn, Patrick Debusha Sargent, LFACHE, Leroy Harris, Jr., Stephanie Trunzo

5

2 Comments

Over the past two decades, the healthcare landscape has evolved significantly, marked by a surge in diverse data sources and an expansion of therapeutic choices. Stakeholders, including patients, healthcare providers, and payers, now seek and utilize complex information with a higher level of sophistication. This proliferation of data has led to increased expectations and demands for more intricate knowledge from all involved. Transforming medical leadership beyond traditional roles is essential in light of these changes. Diversification of expertise, development of business acumen, and a revised approach to measuring performance will be key for this transformation. #HealthcareLeadership #MedicalInnovation #DataTransformation #medicalaffairs

40

Healthtech investment 💰 is the force behind innovation 💡. Strategic funding can promote ethical tech use 📱 and even out healthcare disparities 🏥. Each dollar invested in healthtech shapes the future of healthcare 👩‍⚕️. Let's discuss how financial strategies impact healthtech. Thoughts below! 💭

2

If AI is going to be more than hype and hallucinations, the trillion-dollar pharma industry is where the magic may happen. My latest for Fortune. No one is more ready to make AI's promise come true than Sanofi CEO Paul Hudson. Last week, Hudson proudly announced his company’s new partnership with OpenAI and Formation Bio, a biotech. In the first-of-its-kind partnership, Sanofi will give OpenAI access to its databases, hoping that generative AI can be the key to quicker and more effective drug development. “Large-language models give us this insane opportunity to suppress, summarize, and create,” Hudson told me on the phone from Paris. “It can help us get to a level in R&D where you can design a [drug candidate’s] molecular structure or identify appropriate patients that a drug will benefit.” Is this then the generative AI application the world has been waiting for?  “It costs us 3-4 billion [dollars] to develop a drug, and 80% fail in phase 1 clinical trials,” Hudson said. “I’d like to know in advance what will fail. [Our collaboration with OpenAI] is putting that money to work in other projects with a higher probability of success.” Neither is the promise of #AI in #healthcare years or decades away, Hudson believes. The first results of Sanofi’s OpenAI collaboration should be in by the end of 2024 and will most likely take the form of AI-generated first drafts of FDA documents. The results of the more profound work on research and development and drug discovery should follow soon after. “I want to see early signs next year,” he said. Still, whether this new partnership will indeed one day unlock billions of dollars in savings or new blockbuster revenues remains to be seen. But Hudson did stress that it is this kind of tie-up between industry and AI innovators on cutting-edge and high-value projects is the real deal. “We knew we needed to not just buy a license [for the internal use of OpenAI],” he said. There’s a certain vanity to such licensing deals, which essentially create a “powerful Google.” “You can feel good about [OpenAI licensing]. You can write a press release.” This partnership, however, “is less about that, and more about operationalizing LLMs.” https://lnkd.in/eqz94fVF

21

4 Comments

The article discusses how technology is improving medication management for senior citizens, specifically those receiving care at home. The system mentioned in the article uses a dispenser that provides pre-organized doses at the push of a button, along with real-time pharmacy services to refill medications. This can potentially simplify medication routines and reduce stress for both elderly patients and their caregivers. Let us know your thoughts about this, feel free to share it in the comments section! Call us! T: (510)-573-0064 A: 5886 Mowry School Rd, Newark CA, 94560 #LongTermCare #MedicationManagement #BetterHealth #Teamwork #TIBPharmacy #NewarkPharmacy #pharmacyservices #longtermcare #LTCPharmacy #HospicePharmacy #EndOfLifeCare #hospicespecialized #ltcspecialized #ltcathome #enteraltherapy #MedicationManagement #PackagingPower #SimplifyYourHealth https://lnkd.in/ggkhuiDr

1

1 Comment

Thoughts on this? >> US Fed’s John Williams Williams Sees No Current Reason To Change Stance Of Policy >> Comment below! >>> lqventures.com #digitalhealth #socialmedia #digitalmarketing #industry40 #mhealth #AI #healthtech #IoT

1

#AI can help us deliver healthcare in a world with too few doctors, according to ZS CEO Pratap Khedkar and Principal Ahmed Albaiti. Find out the shifts the industry will need to make—and why the authors are optimistic about a future of healthcare abundance. https://lnkd.in/euCuqhsB

7

Getting the right care shouldn’t be difficult. In our latest article, Ellen Cappelino and I show how generative AI is creating a “Win4All” scenario for patients, providers, payers, and pharma companies. ✨In this new piece, Ellen and I explore how AI-driven solutions enhance transparency, improve decision-making, and boost patient outcomes across the healthcare ecosystem. The article covers how AI: - Gives patients clear information about their coverage and treatment options - Helps healthcare providers make better treatment decisions and improve patient care - Enables payers to lower administrative costs and prevent expensive complications 🔍 Read the full article to see how AI is reshaping healthcare, creating efficiencies, and lowering costs: https://lnkd.in/epkfd7ig #AIinHealthcare #PatientAccess #SustainableHealthcare #Win4All

9

For the last year, I've been an old dog, learning new tricks and working with Tech Doctor on developing their global business. I'm excited to work with Tech Doctor partnering with Digital Medicine Society (DiMe) on this important project to develop a business case for digital endpoints. Since 2019, Tech Doctor has been leveraging wearable devices, acquiring, cleaning, labelling, and analyzing data to develop #digitalbiomarkers. Researchers and others can use our SelfBase platform to use real-time and longitudinal data to develop diagnostics and therapeutics with greater effectiveness and efficiency. My experience in tech and global business development and management has helped with this work, but I have also been drinking from the proverbial firehose to understand a new industry in health and medicine. #digitalmedicine #medtech

12

1 Comment